TABLE 1.
SpCas9 | ||||||
---|---|---|---|---|---|---|
SaCas9 IL2RG | DMD | GAPDH | P53 | Site 5 | ABE Site 5 | |
GFP‐reporter cells | 48.2%a | 51.4%b | ND | ND | ND | ND |
HEK293T | ND | ND | 15.7%c | 16.1%d | 35.5%d | 39.7%c |
MDA‐MB‐231 | ND | ND | 14.4%d | 33.8%d | 24.2%c |
For all assays, EVs were added to 2.5 × 104 cells.
aEVs produced by 0.6 million cells in 48 h were added to HBB‐IL2RG GFP‐reporter cells.
bEVs produced by 2.5 million cells were added to DMD GFP‐reporter cells.
cEVs produced by 5 million cells were added to the respective cells.
dEVs produced by 20 million cells were added to the respective cells.